CRT 2024

DurAVR Biomimetic Transcatheter Heart Valve: Early Feasibility Study (EFS) Update

Speaker(s)

• 

  Thomas Waggoner, DO, FACC, FSCAI, FSVM, RPVI

  Director Structural Heart, Director Cardiovascular Research, Direct Advanced Cardiac Fellowships.
  US Heart & Vascular, Tucson Medical Center

  No relationships to disclose